Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial

Some patients with COVID-19 pneumonia develop an associated cytokine storm syndrome that aggravates the pulmonary disease. These patients may benefit of anti-inflammatory treatment. The role of colchicine in hospitalized patients with COVID-19 pneumonia and established hyperinflammation remains unex...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecconi, Alberto, Martinez-Vives, Pablo, Vera, Alberto, Lavilla Olleros, Cristina, Barrios, Ana, Fonseca Aizpuru, Eva, Roquero, Pilar, Hernandez Muñiz, Susana, Olivera, Maria Jose, Ciudad, Marianela, Pampin Sanchez, Ruben, Fernandez-Madera Martínez, Rosa, Bautista-Hernández, Azucena, García Castillo, Elena, Iturricastillo, Gorane, Ávalos, Elena, Prada Cotado, Diana, Alejandre de Oña, Alvaro, Fernandez Carracedo, Eduardo, Marcos-Jimenez, Ana, Sanz-Garcia, Ancor, Alfranca, Aranzazu, Cecconi, Maurizio, de La Fuente, Hortensia, Sanz de Benito, Maria Angeles, Caballero, Paloma, Sanchez-Madrid, Francisco, Ancochea, Julio, Suarez, Carmen, Jimenez-Borreguero, Luis Jesus, Alfonso, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161184/
https://www.ncbi.nlm.nih.gov/pubmed/35654818
http://dx.doi.org/10.1038/s41598-022-13424-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161184/
https://www.ncbi.nlm.nih.gov/pubmed/35654818
http://dx.doi.org/10.1038/s41598-022-13424-6

Ejemplares similares